Core Viewpoint - Hims & Hers Health has launched an affordable treatment plan for perimenopausal and menopausal individuals, expanding its business into hormone replacement therapy [1] Group 1: Business Expansion - The new menopause care service is expected to help the "Hers" division achieve over $1 billion in annual revenue next year [1] - The company experienced a stock price increase of over 20% during trading, closing up 16.18% on Wednesday, although it fell by 1.93% in after-hours trading [1] Group 2: Treatment Offerings - Patients can collaborate with healthcare providers on the platform to access treatment plans for menopause and perimenopause, which include prescription medications, patches, or creams [1] - The treatment plans may utilize hormones such as estradiol and progesterone, with estradiol alleviating symptoms like hot flashes and night sweats, while progesterone helps improve sleep quality and protects the uterine lining [1]